ScholarWorks@Hanyang University ERICA Campus: Hah, Jung Mi

Detailed Information

Hah, Jung Mi (하정미)

COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)

Research Area: 의약화학, 화학 생물학, 생유가 화학, Medicinal Chemistry, Chemical Biology, Bioorganic Chemistry

Tel 031-400-5803
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Antiproliferative activity:12||3DQSAR:8||Selectivity:8||JNK3:7||Melanoma:6||Alzheimer's disease:5||cancer:5||Melanoma cell line:5||Kinase inhibitor:5||JNK:5||CoMSIA:4||SAR:4||CRAF:4||CoMFA:4||Neurodegenerative disease:3||FLT3:3||molecular docking:3||neurodegenerative diseases:3||Neurodegenerative diseases:3||Kinase selectivity:3||selectivity:3||QSAR:2||BRAF V600E:2||article:2||1,2,3Triazole:2||allosteric:2||inhibitors:2||Anticancer:2||FLT3ITD:2||Benzimidazole:2||Click chemistry:2||protein kinase:2||Hematopoietic cell line:2||benzimidazole:2||CHARGES:1||CSF1R:1||Cancer cell line:1||Chemistryoriented synthesis:1||Combinatorial screening:1||Cycloamylose:1||Cyclodextrins:1||DAPK:1||DISCOVERY:1||DRUG DESIGN:1||Diarylamide:1||Diarylurea:1||Dihydropyrazolodiazepinone:1||Drug design:1||ERK inhibitors:1||FLEXIBLE DOCKING:1||FLT3D835Y:1||FLT3TKD:1||FMS:1||Fibroblast cell line:1||Flurbiprofen:1||HQSAR:1||HS 27:1||HYDROPHOBIC ENCLOSURE:1||Hetero DielsAlder reaction:1||Hybridization:1||IRAK4:1||Imidazole:1||Indazole:1||Initial population:1||JNK inhibitors:1||LMP2 calculation:1||Lead optimization:1||Library:1||Lucentamycin A:1||METALLOPROTEINS:1||MMPBSA:1||MOLECULAR DOCKING:1||Methyloxazole:1||Molecular docking:1||Molecular docking simulation:1||Molecular shape:1||Multiple protein kinase inhibitor:1||NO inhibitory effect:1||Natural product:1||Neuroblastoma cell line:1||Neurodegenerative:1||Neuroinflammation:1||Neuroprotective agents:1||Neuroprotective effect:1||PDBBIND DATABASE:1||PLK1:1||PROTEINLIGAND COMPLEXES:1||Particle swarm optimization:1||Peptides:1||Pharmacophore:1||Pololike kinase 1 (PLK1):1||Pyrazole:1||Pyrazolylpyrrole:1||Pyridinylcarbonylpyrimidines:1||Pyrimidin4yl1Himidazol2yl derivatives:1||Pyrrolo[2,3d]pyrimidine:1||PythDock:1||QM/MM:1||Quantitative structureactivity relationship:1||RIPK:1||Receptorguided alignment:1||Reductive cyclization:1||Ring groups:1||SCORING FUNCTIONS:1||Scoring function:1||Sidechain hopping:1||Solubility:1||Structure revision:1||Structureactivity relationship:1||Synthesis:1||TGFbeta type 1 receptor kinase:1||TYROSINE KINASES:1||Tubulysin:1||VEGFR:1||Virtual screening:1||Ymaze test:1||acetonitrile:1||acetylene:1||aldehyde:1||alkene:1||autoimmune disease:1||biotransformation:1||cJun Nterminal kinase:1||chemotherapy:1||chirality:1||chlor:1||cognitive deficit:1||conformational restriction:1||covalent inhibitors:1||deprotection reaction:1||dichloromethane:1||drug discovery:1||dynamics simulation:1||enantioselectivity:1||gamma turn:1||human diseases:1||imidazole:1||inhibitor:1||kinase:1||kinase inhibitors:1||kinases:1||l 783277:1||lactone derivative:1||liquid chromatography:1||macrocyclic inhibitors:1||macrolactonization:1||mass spectrometry:1||methyl group:1||necrostatin1:1||neuroprotection:1||peptidomimetics:1||phenyl derivatives:1||pipi interaction:1||polycyclic aromatic hydrocarbon derivative:1||pyrazole:1||pyrimidine derivative:1||quantum yield:1||quinazoline:1||reaction analysis:1||reaction time:1||scaffold hopping:1||smallmolecule protein kinase inhibitor:1||sulfur derivative:1||synthesis:1||tau hyperphosphorylation:1||tetrahydrocyclopenta[d]imidazole:1||type III inhibitors:1||(4Aminobenzyl)1Himidazol1yl pyrimidin2yl derivatives:1||unclassified drug:1||1,2Diaryl1Hbenzimidazole:1||1,4Dihydropyrazolo[4,3d]imidazole:1||1,5oxaza spiroquinone:1||1,6Enynes:1||3xTg mouse:1||4Arylthieno[1,4] diazepin2one:1||4arylamido 3methyl isoxazoles:1||A aggregation:1||A375:1||A375 human melanoma cell line:1||A375P:1||ACQUISITION:1||ALK5:1||APP/PS1:1||Acet(benz)amidophenyl:1||Active site:1||Alzheimer's disease (AD):1||Aminopyrazole amide:1||Aminoquinazolines:1||Aminoquinolines:1||Anticancer agent:1||Antitumor agents:1||Asymmetric catalysis:1||Aurora kinase:1||BRaf:1||BRAF:1||BRAF(v600E):1||BRAF(wt) CRAF:1||BRAFV600E:1||BRAFWT:1||Bioavailability:1||CATALYTIC SUBUNIT:1||CD73:1||

RSS_1.0 RSS_2.0 ATOM_1.0

55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE